Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., … Nutt, D. J.. (2021). Trial of Psilocybin versus Escitalopram for Depression. New England Journal of Medicine

Plain numerical DOI: 10.1056/nejmoa2032994
DOI URL
directSciHub download

Al-Naggar, R. A., Alshaikhli, H., & Erlam, G.. (2021). Effectiveness of psilocybin on depression: A qualitative study. Electronic Journal of General Medicine

Plain numerical DOI: 10.29333/ejgm/10862
DOI URL
directSciHub download

Heuschkel, K., & Kuypers, K. P. C.. (2020). Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review. Frontiers in Psychiatry

Plain numerical DOI: 10.3389/fpsyt.2020.00224
DOI URL
directSciHub download

Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R.. (2017). Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression. Journal of Humanistic Psychology

Plain numerical DOI: 10.1177/0022167817709585
DOI URL
directSciHub download

Patra, S.. (2016). Return of the psychedelics: Psilocybin for treatment resistant depression. Asian Journal of Psychiatry

Plain numerical DOI: 10.1016/j.ajp.2016.08.010
DOI URL
directSciHub download

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., … Schmidt, B. L.. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116675512
DOI URL
directSciHub download

Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., … Nutt, D. J.. (2018). Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-017-4771-x
DOI URL
directSciHub download

Goldberg, S. B., Pace, B. T., Nicholas, C. R., Raison, C. L., & Hutson, P. R.. (2020). The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis. Psychiatry Research

Plain numerical DOI: 10.1016/j.psychres.2020.112749
DOI URL
directSciHub download

Więckiewicz, G., Stokłosa, I., Piegza, M., Gorczyca, P., & Pudlo, R.. (2021). Lysergic acid diethylamide, psilocybin and dimethyltryptamine in depression treatment: A systematic review. Pharmaceuticals

Plain numerical DOI: 10.3390/ph14080793
DOI URL
directSciHub download

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … Klinedinst, M. A.. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116675513
DOI URL
directSciHub download

Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L.. (2018). Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology

Plain numerical DOI: 10.1016/j.neuropharm.2017.12.041
DOI URL
directSciHub download

Roseman, L., Nutt, D. J., & Carhart-Harris, R. L.. (2018). Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology

Plain numerical DOI: 10.3389/fphar.2017.00974
DOI URL
directSciHub download

Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., … Nutt, D. J.. (2017). Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms. Scientific Reports

Plain numerical DOI: 10.1038/s41598-017-13282-7
DOI URL
directSciHub download

NCT03380442. (2017). Psilocybin and Depression. Psilocybin and Depression – Assessing the Long-Term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression

Vargas, A. S., Luís, Â., Barroso, M., Gallardo, E., & Pereira, L.. (2020). Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening diseases-a systematic review and meta-analysis of clinical trials. Biomedicines

Plain numerical DOI: 10.3390/biomedicines8090331
DOI URL
directSciHub download

Tai, S. J., Nielson, E. M., Lennard-Jones, M., Johanna Ajantaival, R. L., Winzer, R., Richards, W. A., … Malievskaia, E.. (2021). Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research. Frontiers in Psychiatry

Plain numerical DOI: 10.3389/fpsyt.2021.586682
DOI URL
directSciHub download

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., … Nutt, D. J.. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry

Plain numerical DOI: 10.1016/S2215-0366(16)30065-7
DOI URL
directSciHub download

Corrigan, A. E., Burchill, E., Pelton, L., Marrocu, A., Mazzoleni, A., & Shackshaft, L.. (2021). Psilocybin: the magic medicine for depression?. BJPsych Open

Plain numerical DOI: 10.1192/bjo.2021.456
DOI URL
directSciHub download

Meikle, S. E., Liknaitzky, P., Rossell, S. L., Ross, M., Strauss, N., Thomas, N., … Castle, D. J.. (2020). Psilocybin-assisted therapy for depression: How do we advance the field?. Australian and New Zealand Journal of Psychiatry

Plain numerical DOI: 10.1177/0004867419888575
DOI URL
directSciHub download

Daws, R., Timmerman, C., Giribaldi, B., Sexton, J., Erritzoe, D., Roseman, L., … Carhart-Harris, R.. (2021). Decreased brain modularity after psilocybin therapy for depression. PREPRINT (Version 1) Available at Research Square [Https://Doi.Org/10.21203/Rs.3.Rs-513323/V1]

Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L.. (2020). Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881119895520
DOI URL
directSciHub download

Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K., & Nichols, C. D.. (2020). Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression. ACS Applied Materials and Interfaces

Plain numerical DOI: 10.1021/acschemneuro.9b00493
DOI URL
directSciHub download

Malone, T. C., Mennenga, S. E., Guss, J., Podrebarac, S. K., Owens, L. T., Bossis, A. P., … Ross, S.. (2018). Individual experiences in four cancer patients following psilocybin-assisted psychotherapy. Frontiers in Pharmacology

Plain numerical DOI: 10.3389/fphar.2018.00256
DOI URL
directSciHub download

Li, N. X., Hu, Y. R., Chen, W. N., & Zhang, B.. (2022). Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. Journal of Affective Disorders

Plain numerical DOI: 10.1016/j.jad.2021.09.041
DOI URL
directSciHub download

O’Donnell, K. C., Mennenga, S. E., & Bogenschutz, M. P.. (2019). Psilocybin for depression: Considerations for clinical trial design. Journal of Psychedelic Studies

Plain numerical DOI: 10.1556/2054.2019.026
DOI URL
directSciHub download

Lyons, T., & Carhart-Harris, R. L.. (2018). Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881117748902
DOI URL
directSciHub download

Nutt, D.. (2019). Psychedelic drugs—a new era in psychiatry?. Dialogues in Clinical Neuroscience

Plain numerical DOI: 10.31887/DCNS.2019.21.2/dnutt
DOI URL
directSciHub download

Suppes, T., Lyu, J., & Hambro, B.. (2019). Psilocybin in the treatment of depression and anxiety. Bipolar Disorders

Lyons, T., & Carhart-Harris, R. L.. (2018). More realistic forecasting of Future Life Events after psilocybin for treatment-resistant depression. Frontiers in Psychology

Plain numerical DOI: 10.3389/fpsyg.2018.01721
DOI URL
directSciHub download

Psilocybin for Depression. (2021). New England Journal of Medicine

Plain numerical DOI: 10.1056/nejmc2108082
DOI URL
directSciHub download

Mahapatra, A., & Gupta, R.. (2017). Role of psilocybin in the treatment of depression. Therapeutic Advances in Psychopharmacology

Plain numerical DOI: 10.1177/2045125316676092
DOI URL
directSciHub download

Kelly, J. R., Crockett, M. T., Alexander, L., Haran, M., Baker, A., Burke, L., … O’Keane, V.. (2021). Psychedelic science in post-COVID-19 psychiatry. Irish Journal of Psychological Medicine

Plain numerical DOI: 10.1017/ipm.2020.94
DOI URL
directSciHub download

Lyu, J., Hambro, B., & Suppes, T.. (2019). A SYSTEMATIC REVIEW OF PSILOCYBIN IN THE TREATMENT OF DEPRESSION AND ANXIETY. Journal of Affective Disorders

Plain numerical DOI: 10.1016/j.jad.2018.10.335
DOI URL
directSciHub download

Stroud, J. B., Freeman, T. P., Leech, R., Hindocha, C., Lawn, W., Nutt, D. J., … Carhart-Harris, R. L.. (2018). Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-017-4754-y
DOI URL
directSciHub download

Carrillo, F., Sigman, M., Fernández Slezak, D., Ashton, P., Fitzgerald, L., Stroud, J., … Carhart-Harris, R. L.. (2018). Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. Journal of Affective Disorders

Plain numerical DOI: 10.1016/j.jad.2018.01.006
DOI URL
directSciHub download

Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., … Carhart-Harris, R.. (2018). The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-017-4820-5
DOI URL
directSciHub download

Johnson, M. W., & Griffiths, R. R.. (2017). Potential Therapeutic Effects of Psilocybin. Neurotherapeutics

Plain numerical DOI: 10.1007/s13311-017-0542-y
DOI URL
directSciHub download

Watts, R., & Luoma, J. B.. (2020). The use of the psychological flexibility model to support psychedelic assisted therapy. Journal of Contextual Behavioral Science

Plain numerical DOI: 10.1016/j.jcbs.2019.12.004
DOI URL
directSciHub download

Cowen, P.. (2016). Altered states: psilocybin for treatment-resistant depression. The Lancet Psychiatry

Plain numerical DOI: 10.1016/S2215-0366(16)30087-6
DOI URL
directSciHub download

McCorvy, J. D., Olsen, R. H. J., & Roth, B. L.. (2016). Psilocybin for depression and anxiety associated with life-threatening illnesses. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116675771
DOI URL
directSciHub download

Whelan, A., & Johnson, M. I.. (2018). Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?. Pain Management

Plain numerical DOI: 10.2217/pmt-2017-0068
DOI URL
directSciHub download

Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., … Ross, S.. (2020). Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881119897615
DOI URL
directSciHub download

Savalia, N. K., Shao, L. X., & Kwan, A. C.. (2021). A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics. Trends in Neurosciences

Plain numerical DOI: 10.1016/j.tins.2020.11.008
DOI URL
directSciHub download

Carhart-Harris, R. L., & Goodwin, G. M.. (2017). The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology

Plain numerical DOI: 10.1038/npp.2017.84
DOI URL
directSciHub download

Carhart-Harris, R.. (2015). Results: Of a multi-modal neuroimaging study of LSD and a psilocybin for treatment-resistant depression clinical trial. Neuropsychopharmacology

EUCTR2017-000219-18-GB. (2018). Assessing psilocybin as a treatment for depression. Www.Who.Int/Trialsearch/Trial2.Aspx?TrialID=EUCTR2017-000219-18-GB

Majić, T., Jungaberle, H., Schmidt, T. T., Zeuch, A., Hermle, L., & Gallinat, J.. (2017). Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges. Fortschritte Der Neurologie Psychiatrie

Plain numerical DOI: 10.1055/s-0043-103085
DOI URL
directSciHub download

Thomas, K., Malcolm, B., & Lastra, D.. (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2017.1320734
DOI URL
directSciHub download

Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart-Harris, R. L.. (2018). Effects of psilocybin therapy on personality structure. Acta Psychiatrica Scandinavica

Plain numerical DOI: 10.1111/acps.12904
DOI URL
directSciHub download

Camile, B.. (2019). Psilocybin based therapy for cancer related distress, a systematic review and meta analysis. ArXiv

Jones, T. K., & Lippmann, S.. (2020). Psilocybin Can Diminish Depression. The Primary Care Companion for CNS Disorders

Plain numerical DOI: 10.4088/PCC.19br02580
DOI URL
directSciHub download

Euctr, G. B.. (2020). A Trial of Psilocybin in Clinical Depression Resistant to Standard Treatments. Libdb.Csu.Edu.Cn:80/Rwt/TCL/Http/P75YPLUYNBYT64LPPE/Trialsearch/Trial2.Aspx?TrialID=EUCTR2018-003573-97-GB

S., P.. (2016). Return of the psychedelics: Psilocybin for treatment resistant depression. Asian Journal of Psychiatry

Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C., & O’keane, V.. (2019). The psychedelic renaissance: The next trip for psychiatry?. Irish Journal of Psychological Medicine

Plain numerical DOI: 10.1017/ipm.2019.39
DOI URL
directSciHub download

Chahar, D. Y. K.. (2021). Unmet need in depression: Psilocybin, a breakthrough treatment option. International Journal of Advanced Research in Medicine

Plain numerical DOI: 10.22271/27069567.2021.v3.i1f.159
DOI URL
directSciHub download

Silveira, F. M., Mendes, A. P., Santos, M. R. dos, Cerchi, J. R., Umeda, I. T. T., Melo, B. B. de, … Abdalla, D. R.. (2021). Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders – integrative review. Research, Society and Development

Plain numerical DOI: 10.33448/rsd-v10i10.19297
DOI URL
directSciHub download

Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., … McDonald, W. M.. (2020). Psychedelics and psychedelic-assisted psychotherapy. American Journal of Psychiatry

Plain numerical DOI: 10.1176/appi.ajp.2019.19010035
DOI URL
directSciHub download

Psiuk, D., Nowak, E., Cholewa, K., Łopuszańska, U., & Samardakiewicz, M.. (2021). The potential role of serotonergic hallucinogens in depression treatment. Life

Plain numerical DOI: 10.3390/life11080765
DOI URL
directSciHub download

de Veen, B. T. H., Schellekens, A. F. A., Verheij, M. M. M., & Homberg, J. R.. (2017). Psilocybin for treating substance use disorders?. Expert Review of Neurotherapeutics

Plain numerical DOI: 10.1080/14737175.2016.1220834
DOI URL
directSciHub download

Nutt, D.. (2016). Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116675754
DOI URL
directSciHub download

Nayak, S. M., Gukasyan, N., Barrett, F. S., Erowid, E., Erowid, F., & Griffiths, R. R.. (2021). Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry

Plain numerical DOI: 10.1055/a-1524-2794
DOI URL
directSciHub download

Nichols, D. E.. (2020). Psilocybin: from ancient magic to modern medicine. Journal of Antibiotics

Plain numerical DOI: 10.1038/s41429-020-0311-8
DOI URL
directSciHub download

Fricke, J., Lenz, C., Wick, J., Blei, F., & Hoffmeister, D.. (2019). Production Options for Psilocybin: Making of the Magic. Chemistry – A European Journal

Plain numerical DOI: 10.1002/chem.201802758
DOI URL
directSciHub download

Panels, Mini-Panels and Study Groups. (2015). Neuropsychopharmacology

Plain numerical DOI: 10.1038/npp.2015.324
DOI URL
directSciHub download

Study: Psilocybin enhances therapy in patients with major depression. (2021). The Brown University Psychopharmacology Update

Plain numerical DOI: 10.1002/pu.30675
DOI URL
directSciHub download

Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B., & Thompson, S. M.. (2021). Harnessing psilocybin: Antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proceedings of the National Academy of Sciences of the United States of America

Plain numerical DOI: 10.1073/pnas.2022489118
DOI URL
directSciHub download

Jefsen, O., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D. J., Wegener, G., & Müller, H. K.. (2019). Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat. Acta Neuropsychiatrica

Plain numerical DOI: 10.1017/neu.2019.15
DOI URL
directSciHub download

Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X.. (2015). Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biological Psychiatry

Plain numerical DOI: 10.1016/j.biopsych.2014.04.010
DOI URL
directSciHub download

Donovan, L. L., Johansen, J. V., Ros, N. F., Jaberi, E., Linnet, K., Johansen, S. S., … Knudsen, G. M.. (2021). Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig. European Neuropsychopharmacology

Plain numerical DOI: 10.1016/j.euroneuro.2020.11.013
DOI URL
directSciHub download

Fricke, J., Sherwood, A., Kargbo, R., Orry, A., Blei, F., Naschberger, A., … Hoffmeister, D.. (2019). Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin. ChemBioChem

Plain numerical DOI: 10.1002/cbic.201900358
DOI URL
directSciHub download

Majić, T., Jungaberle, H., Schmidt, T., Zeuch, A., Hermle, L., & Gallinat, J.. (2017). Psychotherapie mit adjuvanter Gabe von serotonergen psychoaktiven Substanzen – Möglichkeiten und Hindernisse. Fortschritte Der Neurologie · Psychiatrie

Plain numerical DOI: 10.1055/s-0043-103085
DOI URL
directSciHub download

Saplakoglu, Y.. (2019). FDA Calls Psychedelic Psilocybin a “Breakthrough Therapy” for Severe Depression

Germann, C. B.. (2020). The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging. Medical Hypotheses

Plain numerical DOI: 10.1016/j.mehy.2019.109406
DOI URL
directSciHub download

Galvão-Coelho, N. L., Marx, W., Gonzalez, M., Sinclair, J., de Manincor, M., Perkins, D., & Sarris, J.. (2021). Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-020-05719-1
DOI URL
directSciHub download

Mason, N. L., Mischler, E., Uthaug, M. V., & Kuypers, K. P. C.. (2019). Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2019.1580804
DOI URL
directSciHub download

Shukuroglou, M., Roseman, L., Wall, M., Nutt, D., Carhart-Harris, R., & Kaelen, M.. (2019). Changes in music-evoked emotion and ventral-striatum functional connectivity following psilocybin therapy for depression. Brain and Neuroscience Advances

Higgins, G. A., Carroll, N. K., Brown, M., MacMillan, C., Silenieks, L. B., Thevarkunnel, S., … Sellers, E. M.. (2021). Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property. Frontiers in Pharmacology

Plain numerical DOI: 10.3389/fphar.2021.640241
DOI URL
directSciHub download

Adams, A. M., Kaplan, N. A., Wei, Z., Brinton, J. D., Monnier, C. S., Enacopol, A. L., … Jones, J. A.. (2019). In vivo production of psilocybin in E. coli. Metabolic Engineering

Plain numerical DOI: 10.1016/j.ymben.2019.09.009
DOI URL
directSciHub download

Ross, S., Agin-Liebes, G., Lo, S., Zeifman, R. J., Ghazal, L., Benville, J., … Mennenga, S. E.. (2021). Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer. ACS Pharmacology and Translational Science

Plain numerical DOI: 10.1021/acsptsci.1c00020
DOI URL
directSciHub download

Nutt, D., Erritzoe, D., & Carhart-Harris, R.. (2020). Psychedelic Psychiatry’s Brave New World. Cell

Plain numerical DOI: 10.1016/j.cell.2020.03.020
DOI URL
directSciHub download

R., C.-H.. (2015). Results: Of a multi-modal neuroimaging study of LSD and a psilocybin for treatment-resistant depression clinical trial. Neuropsychopharmacology

Strauss, N.. (2017). Psilocybin-assisted therapy for anxiety and depression: Implications for euthanasia. Medical Journal of Australia

Plain numerical DOI: 10.5694/mja17.00081
DOI URL
directSciHub download

Malone, T., Mennenga, S. E., Ross, S., Bossis, A., Guss, J., Babb, J., … Belser, A.. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.. Journal of Psychopharmacology

Bienemann, B., Ruschel, N. S., Campos, M. L., Negreiros, M. A., & Mograbi, D. C.. (2020). Self-reported negative outcomes of psilocybin users: A quantitative textual analysis. PLoS ONE

Plain numerical DOI: 10.1371/journal.pone.0229067
DOI URL
directSciHub download

Geiger, H. A., Wurst, M. G., & Daniels, R. N.. (2018). DARK Classics in Chemical Neuroscience: Psilocybin. ACS Chemical Neuroscience

Plain numerical DOI: 10.1021/acschemneuro.8b00186
DOI URL
directSciHub download

Fricke, J., Kargbo, R., Regestein, L., Lenz, C., Peschel, G., Rosenbaum, M. A., … Hoffmeister, D.. (2020). Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin. Chemistry – A European Journal

Plain numerical DOI: 10.1002/chem.202000134
DOI URL
directSciHub download

Reynolds, C. F.. (2021). Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression – Quo Vadis?. JAMA Psychiatry

Plain numerical DOI: 10.1001/jamapsychiatry.2020.2901
DOI URL
directSciHub download

Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., … Griffiths, R. R.. (2021). Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry

Plain numerical DOI: 10.1001/jamapsychiatry.2020.3285
DOI URL
directSciHub download

dos Santos, R. G., Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. C.. (2018). Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Review of Clinical Pharmacology

Plain numerical DOI: 10.1080/17512433.2018.1511424
DOI URL
directSciHub download

Anderson, B. T., Danforth, A., Daroff, P. R., Stauffer, C., Ekman, E., Agin-Liebes, G., … Woolley, J.. (2020). Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine

Plain numerical DOI: 10.1016/j.eclinm.2020.100538
DOI URL
directSciHub download

C., M., L., M., & C., F.. (2018). Psilocybin: Antidepressive, anxiolytic and antiaddictive effects. European Psychiatry

S., R., A., B., J., G., T., M., S.E., M., K., K., … G., A.-L.. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology

Kuypers, K. P. C.. (2020). The therapeutic potential of microdosing psychedelics in depression. Therapeutic Advances in Psychopharmacology

Plain numerical DOI: 10.1177/2045125320950567
DOI URL
directSciHub download

Stauffer, C. S., Anderson, B. T., Ortigo, K. M., & Woolley, J.. (2021). Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience. ACS Pharmacology and Translational Science

Plain numerical DOI: 10.1021/acsptsci.0c00169
DOI URL
directSciHub download

Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., … Ramaekers, J. G.. (2020). Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology

Plain numerical DOI: 10.1038/s41386-020-0718-8
DOI URL
directSciHub download

US National Library of Medicine. (2018). The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression (P-TRD). Clinicaltrials.Gov

Nutt, D.. (2015). 5HT2a Receptors – a New Target for Depression?. European Psychiatry

Plain numerical DOI: 10.1016/s0924-9338(15)30027-4
DOI URL
directSciHub download

Future Paths in Psychopharmacology. (2019). Dialogues in Clinical Neuroscience

Plain numerical DOI: 10.31887/dcns.2019.21.2
DOI URL
directSciHub download

Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., … Knudsen, G. M.. (2019). Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology

Plain numerical DOI: 10.1038/s41386-019-0324-9
DOI URL
directSciHub download

Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., … Ross, S.. (2017). Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress. Journal of Humanistic Psychology

Plain numerical DOI: 10.1177/0022167817715966
DOI URL
directSciHub download

Vitkauskas, M., & Mathuru, A. S.. (2020). Total recall: Lateral habenula and psychedelics in the study of depression and comorbid brain disorders. International Journal of Molecular Sciences

Plain numerical DOI: 10.3390/ijms21186525
DOI URL
directSciHub download

Kim, K., Che, T., Panova, O., DiBerto, J. F., Lyu, J., Krumm, B. E., … Roth, B. L.. (2020). Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor. Cell

Plain numerical DOI: 10.1016/j.cell.2020.08.024
DOI URL
directSciHub download

Shore, R. J., Ioudovski, P., McKeown, S., Dumont, E., & Goldie, C.. (2019). Mapping psilocybin-assisted therapies: A scoping review. MedRxiv

Plain numerical DOI: 10.1101/2019.12.04.19013896
DOI URL
directSciHub download

Kargbo, R. B.. (2020). Psilocybin Therapeutic Research: The Present and Future Paradigm. ACS Medicinal Chemistry Letters

Plain numerical DOI: 10.1021/acsmedchemlett.0c00048
DOI URL
directSciHub download

Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R.. (2019). Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology and Therapeutics

Plain numerical DOI: 10.1016/j.pharmthera.2018.11.010
DOI URL
directSciHub download

R.L., C.-H., M., B. B., J., R., C.M.J., D., D., E., M., K., … DJ, N.. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.. The Lancet. Psychiatry

Jefsen, O. H., Elfving, B., Wegener, G., & Müller, H. K.. (2021). Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881120959614
DOI URL
directSciHub download

L., R., D.J., N., R.L., C.-H., L., D., & M.B., W.. (2018). Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology

Doblin, R. E., Christiansen, M., Jerome, L., & Burge, B.. (2019). The Past and Future of Psychedelic Science: An Introduction to This Issue. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2019.1606472
DOI URL
directSciHub download

A., W., & M.I., J.. (2018). Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: A potential role?. Pain Management

Begola, M. J., & Schillerstrom, J. E.. (2019). Hallucinogens and their therapeutic use: A literature review. Journal of Psychiatric Practice

Plain numerical DOI: 10.1097/PRA.0000000000000409
DOI URL
directSciHub download

Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstad, A. L., & Greer, G. R.. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry

Plain numerical DOI: 10.1001/archgenpsychiatry.2010.116
DOI URL
directSciHub download

Corrigan, K., Haran, M., McCandliss, C., McManus, R., Cleary, S., Trant, R., … Kelly, J. R.. (2021). Psychedelic perceptions: mental health service user attitudes to psilocybin therapy. Irish Journal of Medical Science

Plain numerical DOI: 10.1007/s11845-021-02668-2
DOI URL
directSciHub download

Dydak, K., Śliwińska-Mossoń, M., & Milnerowicz, H.. (2016). Psilocybin as an alternative medicine for patients suffering from depression. Psychiatria i Psychologia Kliniczna

Plain numerical DOI: 10.15557/pipk.2016.0023
DOI URL
directSciHub download

Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E.. (2018). The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology

Plain numerical DOI: 10.1016/j.neuropharm.2018.05.012
DOI URL
directSciHub download

Ross, S.. (2018). Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. International Review of Psychiatry

Plain numerical DOI: 10.1080/09540261.2018.1482261
DOI URL
directSciHub download

Kringelbach, M. L., Cruzat, J., Cabral, J., Knudsen, G. M., Carhart-Harris, R., Whybrow, P. C., … Deco, G.. (2020). Dynamic coupling of whole-brain neuronal and neurotransmitter systems. Proceedings of the National Academy of Sciences of the United States of America

Plain numerical DOI: 10.1073/pnas.1921475117
DOI URL
directSciHub download

Barbara Geller, M.. (2017). Can Psilocybin Treat Severe Depression?. NEJM Journal Watch

Muttoni, S., Ardissino, M., & John, C.. (2019). Classical psychedelics for the treatment of depression and anxiety: A systematic review. Journal of Affective Disorders

Plain numerical DOI: 10.1016/j.jad.2019.07.076
DOI URL
directSciHub download

ACTRN12619001225101. (2019). Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illness. Www.Who.Int/Trialsearch/Trial2.Aspx?TrialID=ACTRN12619001225101

Rößler, A.. (2020). Psilocybin wirksam bei Major Depression. Pharmazeutische Zeitung

Barnby, J. M., & Mehta, M. A.. (2018). Psilocybin and mental health-don’t lose control. Frontiers in Psychiatry

Plain numerical DOI: 10.3389/fpsyt.2018.00293
DOI URL
directSciHub download

Nichols, D. E.. (2014). The Heffter Research Institute: Past and Hopeful Future. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2014.873688
DOI URL
directSciHub download

R.L., C.-H., M., B. B., C.M.J., D., J., R., R., W., D.E., E., … Nutt, D. J.. (2018). Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology

Lowe, H., Toyang, N., Steele, B., Valentine, H., Grant, J., Ali, A., … Gordon, L.. (2021). The therapeutic potential of psilocybin. Molecules

Plain numerical DOI: 10.3390/molecules26102948
DOI URL
directSciHub download

Linartevichi, V. F., Froza, M. G., Cury, R. de M., & Nascimento, F. P. do. (2021). POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEW. Brazilian Journal of Development

Plain numerical DOI: 10.34117/bjdv7n3-783
DOI URL
directSciHub download

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C.. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology

Plain numerical DOI: 10.1177/2045125316638008
DOI URL
directSciHub download

Foldi, C. J., Liknaitzky, P., Williams, M., & Oldfield, B. J.. (2020). Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models. Frontiers in Neuroscience

Plain numerical DOI: 10.3389/fnins.2020.00043
DOI URL
directSciHub download

A., M., & R, , Gupta. (2017). Role of psilocybin in the treatment of depression. Therapeutic Advances in Psychopharmacology

Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S.. (2019). Replication and extension of a model predicting response to psilocybin. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-019-05279-z
DOI URL
directSciHub download

Berkovitch, L., Roméo, B., Karila, L., Gaillard, R., & Benyamina, A.. (2021). Efficacy of psychedelics in psychiatry, a systematic review of the literature. Encephale

Plain numerical DOI: 10.1016/j.encep.2020.12.002
DOI URL
directSciHub download

Psilocybin shows potential as treatment for depression. (2021). Pharmaceutical Journal

Plain numerical DOI: 10.1211/pj.2016.20201222
DOI URL
directSciHub download

Carhart-Harris, R. L., & Nutt, D. J.. (2016). “Psilocybin: Panacea or placebo?” and “Question-based Drug Development for psilocybin”: Authors’ reply. The Lancet Psychiatry

Vermetten, E., Yehuda, R., Doblin, R., Mithoefer, M., Mithoefer, A., Johnson, M., & Kelmendi, B.. (2019). Should MDMA and psilocybin be used for the treatment of PTSD?. Neuropsychopharmacology

Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., … Hutson, P. R.. (2017). Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. Clinical Pharmacokinetics

Plain numerical DOI: 10.1007/s40262-017-0540-6
DOI URL
directSciHub download

Brooks, M.. (2019). FDA Grants Psilocybin Second Breakthrough Therapy Designation for Resistant Depression

Raval, N. R., Johansen, A., Donovan, L. L., Ros, N. F., Ozenne, B., Hansen, H. D., & Knudsen, G. M.. (2021). A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain. International Journal of Molecular Sciences

Plain numerical DOI: 10.3390/ijms22020835
DOI URL
directSciHub download

Varker, T., Watson, L., Gibson, K., Forbes, D., & O’Donnell, M. L.. (2021). Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2020.1817639
DOI URL
directSciHub download

J.B., S., D.J., N., R.L., C.-H., T.P., F., C., H., W., L., … Carhart-Harris, R. L.. (2018). Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.. Psychopharmacology

Blei, F., Baldeweg, F., Fricke, J., & Hoffmeister, D.. (2018). Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions. Chemistry – A European Journal

Plain numerical DOI: 10.1002/chem.201801047
DOI URL
directSciHub download

Byock, I.. (2018). Taking Psychedelics Seriously. Journal of Palliative Medicine

Plain numerical DOI: 10.1089/jpm.2017.0684
DOI URL
directSciHub download

Knopf, A.. (2021). Psilocybin: Next to treat depression, OCD and nicotine addiction. Alcoholism & Drug Abuse Weekly

Plain numerical DOI: 10.1002/adaw.33204
DOI URL
directSciHub download

T., L., & R.L., C.-H.. (2018). Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Journal of Psychopharmacology

Rucker, J. J., & Young, A. H.. (2021). Psilocybin: From Serendipity to Credibility?. Frontiers in Psychiatry

Plain numerical DOI: 10.3389/fpsyt.2021.659044
DOI URL
directSciHub download

Hamzelou, J.. (2018). Can psychedelic drug help with depression?. New Scientist

Plain numerical DOI: 10.1016/s0262-4079(18)30332-4
DOI URL
directSciHub download

Kraehenmann, R., Schmidt, A., Friston, K., Preller, K. H., Seifritz, E., & Vollenweider, F. X.. (2016). The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. NeuroImage: Clinical

Plain numerical DOI: 10.1016/j.nicl.2015.08.009
DOI URL
directSciHub download

Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., … Erritzoe, D.. (2018). Effects of psilocybin therapy on personality structure ACTA PSYCHIATRICA SCANDINAVICA. Acta Psychiatr Scand

Anderson, B., Danforth, A., Daroff, R., Stauffer, C., Dilley, J., Mitchell, J., & Woolley, J.. (2019). T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors. Biological Psychiatry

Plain numerical DOI: 10.1016/j.biopsych.2019.03.460
DOI URL
directSciHub download

Carhart-Harris, R. L., & Goodwin, G. M.. (2017). The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future THE THERAPEUTIC POTENTIAL OF PSYCHEDELIC DRUGS: TEMPERED OPTIMISM (RLC-H). Neuropsychopharmacology

Sloshower, J., Guss, J., Krause, R., Wallace, R. M., Williams, M. T., Reed, S., & Skinta, M. D.. (2020). Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame. Journal of Contextual Behavioral Science

Plain numerical DOI: 10.1016/j.jcbs.2019.11.002
DOI URL
directSciHub download

Earleywine, M., Ueno, L. F., Mian, M. N., & Altman, B. R.. (2021). Cannabis-induced oceanic boundlessness. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881121997099
DOI URL
directSciHub download

Hutchison, C., & Bressi, S.. (2021). Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments. Clinical Social Work Journal

Plain numerical DOI: 10.1007/s10615-019-00743-x
DOI URL
directSciHub download

TC, M., SE, M., Guss, J., SK, P., LT, O., AP, B., … Ross, S.. (2018). Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.. Frontiers in Pharmacology

Vollenweider, F. X.. (2019). Phenomenology and neuronal correlates of altered self: Teachings from psychedelics. Neuropsychobiology

Young, S. N.. (2013). Single treatments that have lasting effects: Some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Journal of Psychiatry and Neuroscience

Plain numerical DOI: 10.1503/jpn.120128
DOI URL
directSciHub download

Fradkin, D.. (2021). Psilocybin: A brief overview for psychiatric mental health nurse practitioners. Perspectives in Psychiatric Care

Plain numerical DOI: 10.1111/ppc.12888
DOI URL
directSciHub download

Gard, D. E., Pleet, M. M., Bradley, E. R., Penn, A. D., Gallenstein, M. L., Riley, L. S., … Woolley, J. D.. (2021). Evaluating the risk of psilocybin for the treatment of bipolar depression: A review of the research literature and published case studies. Journal of Affective Disorders Reports

Plain numerical DOI: 10.1016/j.jadr.2021.100240
DOI URL
directSciHub download

Benko, J., & Vranková, S.. (2020). Natural psychoplastogens as antidepressant agents. Molecules

Plain numerical DOI: 10.3390/molecules25051172
DOI URL
directSciHub download

Nkadimeng, S. M., Nabatanzi, A., Steinmann, C. M. L., & Eloff, J. N.. (2020). Phytochemical, cytotoxicity, antioxidant and anti-inflammatory effects of psilocybe natalensis magic mushroom. Plants

Plain numerical DOI: 10.3390/plants9091127
DOI URL
directSciHub download

Carhart-Harris, R.. (2020). 4 Psychedelics: therapeutic mechanisms. Journal of Neurology, Neurosurgery & Psychiatry

Plain numerical DOI: 10.1136/jnnp-2020-bnpa.4
DOI URL
directSciHub download

Roiser, J. P., & Rees, G.. (2012). Neuroimaging: A scanner, colourfully. Current Biology

Plain numerical DOI: 10.1016/j.cub.2012.02.033
DOI URL
directSciHub download

Rucker, J. J. H., Jelen, L. A., Flynn, S., Frowde, K. D., & Young, A. H.. (2016). Psychedelics in the treatment of unipolar mood disorders: A systematic review. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116679368
DOI URL
directSciHub download

Carhart-Harris, R. L., Brugger, S., Nutt, D. J., & Stone, J. M.. (2013). Psychiatry’s next top model: Cause for a re-think on drug models of psychosis and other psychiatric disorders. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881113494107
DOI URL
directSciHub download

Griffiths, R.. (2015). A single dose of psilocybin produces substantial and enduring decreases in anxiety and depression in patients with a life-threatening cancer diagnosis: a randomized double-blind trial. Neuropsychopharmacology

Senthilingam, M.. (2020). One dose of “magic mushroom” drug reduces anxiety and depression in cancer patients, study says. CNN

Mahmoudi, E., Faizi, M., Hajiaghaee, R., & Razmi, A.. (2018). Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway. Research Journal of Pharmacognosy

Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T.. (2018). Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry

Plain numerical DOI: 10.1016/j.pnpbp.2017.09.012
DOI URL
directSciHub download

Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa. (2021). OBM Neurobiology

Plain numerical DOI: 10.21926/obm.neurobiol.2102102
DOI URL
directSciHub download

(2019). Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer’s Disease. Case Medical Research

Plain numerical DOI: 10.31525/ct1-nct04123314
DOI URL
directSciHub download

De Gregorio, D., Enns, J. P., Nuñez, N. A., Posa, L., & Gobbi, G.. (2018). D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. In Progress in Brain Research

Plain numerical DOI: 10.1016/bs.pbr.2018.07.008
DOI URL
directSciHub download

Breeksema, J. J., Koolen, M. H. B., Somers, M., & Schoevers, R. A.. (2021). [Treatment with psilocybin: applications for patients with psychiatric disorders].. Nederlands Tijdschrift Voor Geneeskunde

T., P., F., T., M., V., R., A., M., B., P., Z., … J., K.. (2018). The effects of psilocybin on brain EEG activity and connectivity in healthy volunteers-focus on the dynamics of the psychedelic state. European Psychiatry

Veen, B. T. H. De, Schellekens, A. F. A., Verheij, M. M. M., & Judith, R.. (2017). Expert Review of Neurotherapeutics Psilocybin for treating substance use disorders ?. Expert Review of Neurotherapeutics

Pio, G. P., Vitorino, A. M., Aidar, N. B., Magalhães, A. A., Mombelli, E. C., Ferraz, G. M., & Pio, R. P.. (2021). O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression. Brazilian Journal of Health Review

Plain numerical DOI: 10.34119/bjhrv4n2-395
DOI URL
directSciHub download

Sherwood, A. M., & Prisinzano, T. E.. (2018). Novel psychotherapeutics–a cautiously optimistic focus on Hallucinogens. Expert Review of Clinical Pharmacology

Plain numerical DOI: 10.1080/17512433.2018.1415755
DOI URL
directSciHub download

Kvam, T.-M., Stewart, L. H., & Andreassen, O. A.. (2018). Psychedelic drugs in the treatment of anxiety, depression and addiction. Tidsskrift for Den Norske Legeforening

Mertens, L. J., & Preller, K. H.. (2021). Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders. Pharmacopsychiatry

Plain numerical DOI: 10.1055/a-1341-1907
DOI URL
directSciHub download

Nichols, D. E.. (2016). Psychedelics. Pharmacological Reviews

Plain numerical DOI: 10.1124/pr.115.011478
DOI URL
directSciHub download

Flanagan, T. W., & Nichols, C. D.. (2018). Psychedelics as anti-inflammatory agents. International Review of Psychiatry

Plain numerical DOI: 10.1080/09540261.2018.1481827
DOI URL
directSciHub download

Hope, S., & Rosa, W.. (2018). Holistic Care of the Spirit: The Use of Entheogens in Patients with Advanced Serious Illness. Beginnings

Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L.. (2019). P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. European Neuropsychopharmacology

Plain numerical DOI: 10.1016/j.euroneuro.2019.09.593
DOI URL
directSciHub download

Magaraggia, I., Kuiperes, Z., & Schreiber, R.. (2021). Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach. Neurobiology of Learning and Memory

Plain numerical DOI: 10.1016/j.nlm.2021.107467
DOI URL
directSciHub download

Leger, R. F., & Unterwald, E. M.. (2021). Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/02698811211044688
DOI URL
directSciHub download

Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L. A., … Hapke, E.. (2019). Psychedelic microdosing benefits and challenges: An empirical codebook. Harm Reduction Journal

Plain numerical DOI: 10.1186/s12954-019-0308-4
DOI URL
directSciHub download

Sakloth, F., Leggett, E., Moerke, M. J., Townsend, E. A., Banks, M. L., & Negus, S. S.. (2019). Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Experimental and Clinical Psychopharmacology

Plain numerical DOI: 10.1037/pha0000253
DOI URL
directSciHub download

Zamaria, J. A.. (2016). A phenomenological examination of psilocybin and its positive and persisting aftereffects. NeuroQuantology

Plain numerical DOI: 10.14704/nq.2016.14.2.943
DOI URL
directSciHub download

de Gregorio, D., Aguilar-Valles, A., Preller, K. H., Heifets, B. D., Hibicke, M., Mitchell, J., & Gobbi, G.. (2021). Hallucinogens in mental health: Preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine. In Journal of Neuroscience

Plain numerical DOI: 10.1523/JNEUROSCI.1659-20.2020
DOI URL
directSciHub download

Mathai, D. S., Meyer, M. J., Storch, E. A., & Kosten, T. R.. (2020). The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Journal of Affective Disorders

Plain numerical DOI: 10.1016/j.jad.2019.12.023
DOI URL
directSciHub download

Bird, C. I. V., Modlin, N. L., & Rucker, J. J. H.. (2021). Psilocybin and MDMA for the treatment of trauma-related psychopathology. International Review of Psychiatry

Plain numerical DOI: 10.1080/09540261.2021.1919062
DOI URL
directSciHub download

Chi, T., & Gold, J. A.. (2020). A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. Journal of the Neurological Sciences

Plain numerical DOI: 10.1016/j.jns.2020.116715
DOI URL
directSciHub download

Voineskos, D., Daskalakis, Z. J., & Blumberger, D. M.. (2020). Management of treatment-resistant depression: Challenges and strategies. Neuropsychiatric Disease and Treatment

Plain numerical DOI: 10.2147/NDT.S198774
DOI URL
directSciHub download

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V.. (2017). Psychedelic Drugs in Biomedicine. Trends in Pharmacological Sciences

Plain numerical DOI: 10.1016/j.tips.2017.08.003
DOI URL
directSciHub download

NCT03554174. (2018). Psilocybin – Induced Neuroplasticity in the Treatment of Major Depressive Disorder. Clinicaltrials.Gov/Show/NCT03554174

Dos Santos, R. G., Bouso, J. C., & Hallak, J. E. C.. (2019). Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry

Plain numerical DOI: 10.1186/s12888-019-2288-z
DOI URL
directSciHub download

Kiilerich, K., Speth, N., Lorenz, J., Casado-Sainz, A., Shalgunov, V., Lange, D., … Palner, M.. (2019). P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses. European Neuropsychopharmacology

Plain numerical DOI: 10.1016/j.euroneuro.2019.09.271
DOI URL
directSciHub download

Cotovio, G., Maia, A., Velosa, A., Seybert, C., & Oliveira-Maia, A. J.. (2021). Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?. Revista Portuguesa de Psiquiatria e Saúde Mental

Plain numerical DOI: 10.51338/rppsm.2021.v7.i3.241
DOI URL
directSciHub download

Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M.. (2020). Microdosing psychedelics: Motivations, subjective effects and harm reduction. International Journal of Drug Policy

Plain numerical DOI: 10.1016/j.drugpo.2019.11.008
DOI URL
directSciHub download

Hibicke, M., Landry, A. N., Talman, Z. K., & Nichols, C.. (2019). Psychedelics Improve the Mental Health of Rats. The FASEB Journal

Plain numerical DOI: 10.1096/fasebj.2019.33.1_supplement.666.1
DOI URL
directSciHub download

Rucker, J. J. H.. (2019). Psilocybin therapy for major depressive disorder. In Advances in psychedelic medicine: State-of-the-art therapeutic applications.

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. C.. (2017). Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Therapeutic Advances in Psychopharmacology

Plain numerical DOI: 10.1177/2045125316689030
DOI URL
directSciHub download

Schimmel, N., Breeksema, J. J., Veraart, J., Van Den Brink, W., & Schoevers, R. A.. (2020). Psychedelics for existential distress in terminally ill patients. Tijdschrift Voor Psychiatrie

Protocol, S., Griffiths, R. R., Davis, A. K., & Griffiths, R. R.. (2020). eMATERIALS : STUDY PROTOCOL. JAMA Psychiatry

Goldberg, S. B., Shechet, B., Nicholas, C. R., Ng, C. W., Deole, G., Chen, Z., & Raison, C. L.. (2020). Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis. Psychological Medicine

Plain numerical DOI: 10.1017/S003329172000389X
DOI URL
directSciHub download

Tylš, F., Korèák, J., & Horáèek, J.. (2020). PSILOCYBIN: ANTIDEPRESSANT and TRANSFORMATIVE POTENTIAL. Psychiatrie (CZE)

O., J., K., H., B., E., & G., W.. (2018). Psilocybin modulated expression of plasticityrelated genes and proteins in rat prefrontal cortex and hippocampus. Acta Neuropsychiatrica

NCT03715127. (2018). Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients – Proof of Concept. Clinicaltrials

Palenicek, T., Tyls, F., Viktorinova, M., Androvicova, R., Brunovsky, M., Zach, P., … Horacek, J.. (2018). The effects of psilocybin on brain EEG activity and connectivity in healthy volunteers-focus on the dynamics of the psychedelic state. European Psychiatry

Baumeister, D., Barnes, G., Giaroli, G., & Tracy, D.. (2014). Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Therapeutic Advances in Psychopharmacology

Plain numerical DOI: 10.1177/2045125314527985
DOI URL
directSciHub download

Teixeira, P. J., Johnson, M. W., Timmermann, C., Watts, R., Erritzoe, D., Douglass, H., … Carhart-Harris, R. L.. (2021). Psychedelics and health behaviour change. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/02698811211008554
DOI URL
directSciHub download

Kuypers, K. P. C.. (2018). Out of the box: A psychedelic model to study the creative mind. Medical Hypotheses

Plain numerical DOI: 10.1016/j.mehy.2018.03.010
DOI URL
directSciHub download

Bush, H.. (2020). Psychedelic therapy: Fresh promise for mental health. Mental Health Weekly

Plain numerical DOI: 10.1002/mhw.32207
DOI URL
directSciHub download

Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L. A., Hui, K., … Farb, N. A. S.. (2019). Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-018-5106-2
DOI URL
directSciHub download

Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R.. (2020). A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2020.1769878
DOI URL
directSciHub download

Preller, K.. (2021). Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing. Biological Psychiatry

Plain numerical DOI: 10.1016/j.biopsych.2021.02.036
DOI URL
directSciHub download

Preller, K. H., Pokorny, T., Krähenmann, R., Dziobek, I., Stämpfli, P., & Vollenweider, F. X.. (2015). The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making. European Psychiatry

Plain numerical DOI: 10.1016/s0924-9338(15)30017-1
DOI URL
directSciHub download

Varley, J.. (2019). Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens. Journal of Psychedelic Studies

Plain numerical DOI: 10.1556/2054.2019.005
DOI URL
directSciHub download

Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R.. (2016). The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116678781
DOI URL
directSciHub download

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K.. (2020). Long-term effects of psychedelic drugs: A systematic review. Neuroscience and Biobehavioral Reviews

Plain numerical DOI: 10.1016/j.neubiorev.2020.03.017
DOI URL
directSciHub download

Tullis, P.. (2021). How ecstasy and psilocybin are shaking up psychiatry. Nature

Plain numerical DOI: 10.1038/d41586-021-00187-9
DOI URL
directSciHub download

Nichols, D. E.. (2018). Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD). ACS Chemical Neuroscience

Plain numerical DOI: 10.1021/acschemneuro.8b00043
DOI URL
directSciHub download

Bouso, J. C., Ona, G., Dos Santos, R. G., & Hallak, J. E. C.. (2021). Psychedelic Medicines in Major Depression: Progress and Future Challenges. In Advances in Experimental Medicine and Biology

Plain numerical DOI: 10.1007/978-981-33-6044-0_26
DOI URL
directSciHub download

Andersen, K. A. A., Carhart-Harris, R., Nutt, D. J., & Erritzoe, D.. (2021). Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatrica Scandinavica

Plain numerical DOI: 10.1111/acps.13249
DOI URL
directSciHub download

B., A., R., G., P., H., A., G.-R., M., B., S.S., F., & A., W.. (2019).